.gamma.-Glutamyltransferase (.gamma.-GT) exceeded the upper normal limit in 31 of the 32 patients with liver metastases verified during surgery or at autopsy, while the level of this enzyme was normal in 25 of the 28 patients with proven neoplasms, but without evidence of metastatic involvement of the liver. Particularly high values of .gamma.-GT activity were noted in 9 patients in whom liver metastases were accompanied by clinical jaundice. A similar behavior was noted for alkaline phosphatase, but changes affecting this enzyme were less obvious. For a mean increase of .gamma.-GT to levels up to 7 times the upper normal limit, the level of alkaline phosphatase increased only 3 times. A decrease of serum pseudocholinesterase occurred in most patients with neoplasms, the process being more evident when liver metastases were present. An increase of .gamma.-GT in a patient with neoplasms can apparently be considered as a marker of hepatic metastases, if chronic alcoholism or hepatobiliary disease can be excluded.